BioLineRx (BLRX) Other Working Capital Changes (2014 - 2026)

BioLineRx's Other Working Capital Changes history runs 1 years deep, the most recent figure standing at -$2.3 million for Q4 2024.

• In Q4 2025, Other Working Capital Changes rose 230.0% year-over-year to $520000.0; the TTM figure through Dec 2025 stood at $1.3 million (up 3146.51% YoY), while the FY2025 annual figure was $1.3 million, up 3146.51% from the prior year.
• Other Working Capital Changes for Q4 2025 stood at $520000.0, up from -$356000.0 in the prior quarter.
• The five-year high for Other Working Capital Changes was $1.2 million in Q1 2025, with the low at -$976000.0 in Q1 2021.
• The 5-year median for Other Working Capital Changes is -$101500.0 (2022), against an average of -$15900.0.
• The sharpest annual moves came in 2021 and 2025: Other Working Capital Changes tumbled 356.52% in 2021, then soared 1328.4% in 2025.
• BioLineRx's Other Working Capital Changes stood at $372000.0 in 2021, then sank by 164.25% to -$239000.0 in 2022, then tumbled by 64.44% to -$393000.0 in 2023, then fell by 1.78% to -$400000.0 in 2024, then soared by 230.0% to $520000.0 in 2025.
• Business Quant data shows BLRX's Other Working Capital Changes at -$2.3 million in Q4 2024, -$3.2 million in Q3 2024, and -$3.6 million in Q2 2024.